{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:00:52Z","timestamp":1790762452123,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82674792"],"award-info":[{"award-number":["82674792"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373654"],"award-info":[{"award-number":["82373654"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.lanwpc.2026.101983","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:45:49Z","timestamp":1789991149000},"page":"101983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["HBsAg seroclearance with HBV DNA &lt;100 IU\/mL and long-term risks of adverse liver events, all-cause mortality, and cause-specific mortality in chronic hepatitis B: a prospective cohort study"],"prefix":"10.1016","volume":"74","author":[{"given":"Ying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanjie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liguo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6483-9372","authenticated-orcid":false,"given":"Ci","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanwpc.2026.101983_bib1","series-title":"Action for Access in Low- and Middle-Income Countries","year":"2024"},{"key":"10.1016\/j.lanwpc.2026.101983_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.21037\/hbsn-2024-754","article-title":"2024 latest report on hepatitis B virus epidemiology in China: current status, changing trajectory, and challenges","volume":"14","author":"Yan","year":"2025","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.lanwpc.2026.101983_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.5718","article-title":"Associations between hepatitis B virus infection and risk of all cancer types","volume":"2","author":"Song","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.lanwpc.2026.101983_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/liv.13498","article-title":"Spectrum of hepatitis B and renal involvement","volume":"38","author":"Shah","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.lanwpc.2026.101983_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027696","article-title":"Chronic hepatitis B virus infection and total and cause-specific mortality: a prospective cohort study of 0.5 million people","volume":"9","author":"Si","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.lanwpc.2026.101983_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16040711","article-title":"Extrahepatic malignancies are the leading cause of death in patients with chronic hepatitis B without cirrhosis: a large population-based cohort study","volume":"16","author":"Chon","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lanwpc.2026.101983_bib7","series-title":"Global Health Sector Strategy On Viral Hepatitis 2016\u20132021: Towards Ending Viral Hepatitis","year":"2016"},{"issue":"5","key":"10.1016\/j.lanwpc.2026.101983_bib8","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jhep.2023.06.002","article-title":"Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: report from the 2022 AASLD-EASL HBV-HDV treatment endpoints conference","volume":"79","author":"Ghany","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.lanwpc.2026.101983_bib9","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","article-title":"Hepatitis B","volume":"401","author":"Jeng","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.lanwpc.2026.101983_bib10","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jhep.2017.06.019","article-title":"Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance","volume":"67","author":"Yip","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.lanwpc.2026.101983_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/apt.16659","article-title":"Systematic review with meta-analysis: the impact of functional cure on clinical outcomes in patients with chronic hepatitis B","volume":"55","author":"Vittal","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.lanwpc.2026.101983_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyaf005","article-title":"Cohort profile: the chronic hepatitis B infection and liver disease (HEPCARE) study in Jiangsu, China","volume":"54","author":"Jiang","year":"2024","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.lanwpc.2026.101983_bib13","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/sim.4780111204","article-title":"Effects of mid-point imputation on the analysis of doubly censored data","volume":"11","author":"Law","year":"1992","journal-title":"Stat Med"},{"key":"10.1016\/j.lanwpc.2026.101983_bib14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cgh.2020.05.041","article-title":"Association between seroclearance of hepatitis B surface antigen and long-term clinical outcomes of patients with chronic hepatitis B virus infection: systematic review and meta-analysis","volume":"19","author":"Anderson","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101983_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00535-024-02162-3","article-title":"Impact of age at HBsAg seroclearance on hepatic outcomes and life expectancy in men with chronic HBV infection based on multi-state modeling of the natural history","volume":"60","author":"Liu","year":"2025","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.lanwpc.2026.101983_bib16","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1200\/JCO.2012.48.5896","article-title":"Effect of antiviral treatment with nucleotide\/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study","volume":"31","author":"Yin","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lanwpc.2026.101983_bib17","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"Marcellin","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.lanwpc.2026.101983_bib18","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1200\/JCO.21.01285","article-title":"Association of chronic hepatitis B infection and antiviral treatment with the development of the extrahepatic malignancies: a nationwide cohort study","volume":"40","author":"Lee","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lanwpc.2026.101983_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104003","article-title":"Hepatitis B infection is causally associated with extrahepatic cancers: a Mendelian randomization study","volume":"79","author":"Kamiza","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.lanwpc.2026.101983_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1332557","article-title":"Mendelian randomization of chronic hepatitis B and cardiovascular disease","volume":"11","author":"Wu","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.lanwpc.2026.101983_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-021-03210-9","article-title":"Increased burden of cardiovascular disease in people with liver disease: unequal geographical variations, risk factors and excess years of life lost","volume":"20","author":"Chang","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.lanwpc.2026.101983_bib22","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/hep.30833","article-title":"An aging population of chronic hepatitis B with increasing comorbidities: a territory-wide study from 2000 to 2017","volume":"71","author":"Wong","year":"2020","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.lanwpc.2026.101983_bib23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000511585","article-title":"Increasing age and nonliver comorbidities in patients with chronic hepatitis B in Taiwan: a nationwide population-based analysis","volume":"39","author":"Tseng","year":"2021","journal-title":"Dig Dis"},{"key":"10.1016\/j.lanwpc.2026.101983_bib24","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.3390\/ijms22115497","article-title":"Immunopathology of chronic hepatitis B infection: role of innate and adaptive immune response in disease progression","volume":"22","author":"Khanam","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.lanwpc.2026.101983_bib25","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41419-025-08069-y","article-title":"Chronic HBV infection impairs the glucose metabolism and effector function of NK cells via HBsAg\/IL-15\/mTOR axis","volume":"16","author":"Yu","year":"2025","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.lanwpc.2026.101983_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1141956","article-title":"Hepatitis B virus infection: an insight into the clinical connection and molecular interaction between hepatitis B virus and host extrahepatic cancer risk","volume":"14","author":"Min","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.lanwpc.2026.101983_bib27","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.3748\/wjg.v27.i30.5112","article-title":"Na\u00efve hepatitis B e antigen-negative chronic hepatitis B patients are at risk of carotid atherosclerosis: a prospective study","volume":"27","author":"Riveiro-Barciela","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.lanwpc.2026.101983_bib28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jhep.2020.04.013","article-title":"Hepatitis B surface antigen seroclearance: immune mechanisms, clinical impact, importance for drug development","volume":"73","author":"Tout","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.lanwpc.2026.101983_bib29","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/hep.28155","article-title":"Natural killer cell phenotype modulation and natural killer\/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B","volume":"62","author":"Boni","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.lanwpc.2026.101983_bib30","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/cmi.2015.25","article-title":"Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients","volume":"12","author":"Xu","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.lanwpc.2026.101983_bib31","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/v12080864","article-title":"Chronic hepatitis B infection is associated with increased molecular degree of inflammatory perturbation in peripheral blood","volume":"12","author":"Vinhaes","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.lanwpc.2026.101983_bib32","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.lanwpc.2026.101983_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jhep.2018.10.014","article-title":"HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues","volume":"70","author":"Yip","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.lanwpc.2026.101983_bib34","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1002\/hep.22929","article-title":"Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: a systematic review of evidence","volume":"49","author":"Taylor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.lanwpc.2026.101983_bib35","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000290","article-title":"Risk and risk score performance of hepatocellular carcinoma development in patients with hepatitis B surface antigen seroclearance","volume":"12","author":"Park","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.lanwpc.2026.101983_bib36","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1002\/hep.31610","article-title":"Comparison of long-term clinical outcomes between spontaneous and therapy-induced HBsAg seroclearance","volume":"73","author":"Choi","year":"2021","journal-title":"Hepatology"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606526001872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606526001872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:14:48Z","timestamp":1790759688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606526001872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":36,"alternative-id":["S2666606526001872"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2026.101983","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HBsAg seroclearance with HBV DNA <100 IU\/mL and long-term risks of adverse liver events, all-cause mortality, and cause-specific mortality in chronic hepatitis B: a prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2026.101983","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101983"}}